Literature DB >> 9107145

The diagnostic validity of melancholic major depression in a population-based sample of female twins.

K S Kendler1.   

Abstract

BACKGROUND: Although the diagnosis of melancholia is among the oldest in psychiatry, the validity of the melancholic subtype of major depression (MD) is still debated. If melancholia is a valid subtype of depression, is it quantitatively more severe than or qualitatively distinct from nonmelancholic depression?
METHODS: The lifetime history of MD and melancholia, defined by DSM-IV criteria, was assessed at interview in 1902 female twins selected from a population-based register. Patterns of comorbidity and the relationship between melancholia and risk for MD in the co-twin were assessed by logistic regression and Cox proportional hazards models respectively.
RESULTS: In those with a lifetime history of MD, melancholia was associated with the following: (1) increased comorbidity with anxiety disorders and nicotine dependence but not alcohol dependence or bulimia; (2) greater number of episodes, more impairment, and help seeking; (3) lower levels of neuroticism; and (4) an increased risk of MD in cotwins-greater in monozygotic than in dizygotic pairs. Within twin pairs concordant for MD, no resemblance was found for melancholia. A multiple threshold model in which melancholic MD represented a quantitatively more severe form of depressive illness fitted the data well.
CONCLUSIONS: Melancholia, defined by DSM-IV criteria, is a valid subtype of MD and identifies a subset of affected individuals with distinct clinical features and a particularly high familial liability to depressive illness. However, from a familial perspective, the differences between melancholic and nonmelancholic MD are quantitative, not qualitative. ie, melancholic MD is more severe than, but is not etiologically distinct from, nonmelancholic MD.

Entities:  

Mesh:

Year:  1997        PMID: 9107145     DOI: 10.1001/archpsyc.1997.01830160013002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  32 in total

Review 1.  Construct models in veterinary behavioural medicine: lessons from the human experience.

Authors:  G Sheppard; D S Mills
Journal:  Vet Res Commun       Date:  2003-04       Impact factor: 2.459

2.  Associations between subtypes of major depressive episodes and substance use disorders.

Authors:  Naomi R Marmorstein
Journal:  Psychiatry Res       Date:  2010-10-28       Impact factor: 3.222

3.  Genetics of disease: Associations with depression.

Authors:  Patrick F Sullivan
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

4.  Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants.

Authors:  Naho Ichikawa; Giuseppe Lisi; Noriaki Yahata; Go Okada; Masahiro Takamura; Ryu-Ichiro Hashimoto; Takashi Yamada; Makiko Yamada; Tetsuya Suhara; Sho Moriguchi; Masaru Mimura; Yujiro Yoshihara; Hidehiko Takahashi; Kiyoto Kasai; Nobumasa Kato; Shigeto Yamawaki; Ben Seymour; Mitsuo Kawato; Jun Morimoto; Yasumasa Okamoto
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

5.  The Genetic Architecture of Major Depressive Disorder in Han Chinese Women.

Authors:  Roseann E Peterson; Na Cai; Tim B Bigdeli; Yihan Li; Mark Reimers; Anna Nikulova; Bradley T Webb; Silviu-Alin Bacanu; Brien P Riley; Jonathan Flint; Kenneth S Kendler
Journal:  JAMA Psychiatry       Date:  2017-02-01       Impact factor: 21.596

6.  BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression.

Authors:  Timea Rimay; Istvan Benak; Eniko Kiss; Ildiko Baji; Agnes Feher; Anna Juhasz; John Strauss; James Kennedy; Cathy Barr; Maria Kovacs; Agnes Vetro; Krisztina Kapornai
Journal:  Psychiatr Genet       Date:  2015-12       Impact factor: 2.458

7.  Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Authors:  Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-14       Impact factor: 4.035

8.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

9.  Associations between depression subtypes and substance use disorders.

Authors:  Adam M Leventhal; Caren Francione Witt; Mark Zimmerman
Journal:  Psychiatry Res       Date:  2008-09-11       Impact factor: 3.222

10.  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.

Authors:  Richard C Shelton; D Hal Manier; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-02       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.